dc.contributor.author | Ertan-Ahmed, Senem | |
dc.contributor.author | Kiehl, Michael G. | |
dc.contributor.author | Radinoff, Atanas | |
dc.contributor.author | Graklanov, Vasko | |
dc.contributor.author | Tzvetkov, Nikolay | |
dc.contributor.author | Mihaescu, Rodica | |
dc.contributor.author | Sung, Young Chul | |
dc.date.accessioned | 2020-06-21T12:26:54Z | |
dc.date.available | 2020-06-21T12:26:54Z | |
dc.date.issued | 2019 | |
dc.identifier.issn | 0732-183X | |
dc.identifier.issn | 1527-7755 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12712/10834 | |
dc.description | Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- MAY 31-JUN 04, 2019 -- Chicago, IL | en_US |
dc.description | Graklanov, Vasko/0000-0002-7059-1411 | en_US |
dc.description | WOS: 000487345802410 | en_US |
dc.description.abstract | … | en_US |
dc.description.sponsorship | Amer Soc Clin Oncol | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Amer Soc Clinical Oncology | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | GX-G3, a long-acting G-CSF, compared with pegfilgrastim in reducing duration of severe neutropenia after chemotherapy for non-Hodgkin's lymphoma. | en_US |
dc.type | conferenceObject | en_US |
dc.contributor.department | OMÜ | en_US |
dc.identifier.volume | 37 | en_US |
dc.identifier.issue | 15 | en_US |
dc.relation.journal | Journal of Clinical Oncology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |